The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1701
April 29, 2024
View Complete Issue         Table of Contents 2019 
Intravenous Acetaminophen/Ibuprofen (Combogesic IV)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Intravenous Acetaminophen/Ibuprofen (Combogesic IV)
April 29, 2024 (Issue: 1701)
The FDA has approved Combogesic IV (Hikma), an IV solution containing acetaminophen and ibuprofen, to treat mild to moderate pain (alone) or moderate to severe pain (in combination with an opioid) in adults when IV analgesia is considered...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Intravenous Acetaminophen/Ibuprofen (Combogesic IV)
Article code: 1701c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.